These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2961950)
1. Preclinical studies of a panel of 12 monoclonal antibodies in view of bone marrow purging in acute lymphoblastic leukemia. Racadot E; Herve P; Lamy B; Peters A Leuk Res; 1987; 11(11):987-94. PubMed ID: 2961950 [TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging. Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306 [TBL] [Abstract][Full Text] [Related]
3. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia. Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Prendergast M; Berndt MC; Hughes WG; Zola H; Krishnan R; Haylock D Pathology; 1986 Apr; 18(2):197-205. PubMed ID: 2945154 [TBL] [Abstract][Full Text] [Related]
4. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies. Macintyre EA Clin Haematol; 1986 Feb; 15(1):249-67. PubMed ID: 3516492 [No Abstract] [Full Text] [Related]
5. Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML. Majdic O; Sugita K; Touw I; Köller U; Stockinger H; Delwel R; Löwenberg B; Knapp W Haematol Blood Transfus; 1987; 31():86-8. PubMed ID: 3327791 [No Abstract] [Full Text] [Related]
7. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia. Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833 [TBL] [Abstract][Full Text] [Related]
8. Transplantation of monoclonal antibody-purged autologous bone marrow for treatment of poor risk common acute lymphoblastic leukemia. Bradstock KF; Stevens M; Bergin M; Dalla-Pozza L; Duval P; Favaloro EJ; Kabral A; Kerr A; Juttner C; Zola H Aust N Z J Med; 1987 Jun; 17(3):283-9. PubMed ID: 2960307 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood. Niemeyer CM; Ritz J; Donahue K; Sallan SE Haematol Blood Transfus; 1987; 31():67-74. PubMed ID: 2965082 [No Abstract] [Full Text] [Related]
10. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707 [TBL] [Abstract][Full Text] [Related]
12. Purging of bone marrow with a cocktail of monoclonal antibodies (VIB-pool) for autologous transplantation. Zintl F; Reiners B; Thränhardt H; Hermann J; Fuchs D; Prager J Haematol Blood Transfus; 1987; 31():89-91. PubMed ID: 3327792 [No Abstract] [Full Text] [Related]
13. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia. Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834 [TBL] [Abstract][Full Text] [Related]
14. In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia. Ritz J; Sallan SE; Bast RC; Lipton JM; Nathan DG; Schlossman SF Haematol Blood Transfus; 1983; 28():117-23. PubMed ID: 6345287 [No Abstract] [Full Text] [Related]
15. Leukemia diagnosis and testing of complement-fixing antibodies for bone marrow purging in acute lymphoid leukemia. Campana D; Janossy G Blood; 1986 Dec; 68(6):1264-71. PubMed ID: 3535926 [TBL] [Abstract][Full Text] [Related]
16. An immunotoxin for immunologic manipulation of marrow ex vivo in autologous transplantation for common acute lymphoblastic leukemia. Herrmann R; Pelham J; Meyer B; Davis R; Raphael C; Kraft N; Atkins R Transplant Proc; 1986 Apr; 18(2):278-80. PubMed ID: 2938314 [No Abstract] [Full Text] [Related]
17. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Ritz J; Sallan SE; Bast RC; Lipton JM; Clavell LA; Feeney M; Hercend T; Nathan DG; Schlossman SF Lancet; 1982 Jul; 2(8289):60-3. PubMed ID: 6177990 [TBL] [Abstract][Full Text] [Related]
18. Use of a cocktail of monoclonal antibodies and human complement in selective killing of acute lymphocytic leukemia cells. Sugita K; Majdic O; Stockinger H; Holter W; Köller U; Peschel C; Knapp W Int J Cancer; 1986 Mar; 37(3):351-7. PubMed ID: 3456339 [TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow transplantation in acute lymphoblastic leukemia following in vitro treatment with monoclonal antibodies and with complement: analyses for two cases of failure. Ito T; Ishikawa Y; Noda M; Fujii R Jpn J Clin Oncol; 1987 Mar; 17(1):63-9. PubMed ID: 3031335 [TBL] [Abstract][Full Text] [Related]
20. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis. Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]